Gene therapy for renal cancer.

Abstract excerpt

Recent advances in understanding the molecular events associated with renal cell carcinoma (RCC) are revolutionizing the therapeutic options offered for patients with advanced-stage RCC. These targeted approaches for RCC are based primarily on antiangiogenesis and/or specific kinase inhibitors targeting the vascular-endothelial growth factor and platelet-derived growth factor receptors, Raf and mammalian target...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Von Hippel-Lindau Tumor Suppressor Protein
• Share to Carcinoma, Renal Cell
• Share to Gene Transfer Techniques